Today, the American Diabetes Association® (ADA) announced the establishment of the Diabetes Prevention Alliance (DPA), a network of stakeholder partners focused on supporting the National Diabetes ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Diabetes costs US employers over $106B in lost productivity. Learn how data-driven support can improve employee health and ...

Insulet will recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November.

PharmaSens, a developer of insulin patch pumps for people with diabetes, has appointed Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

PharmaSens, a developer of innovative insulin patch pumps for people with diabetes, has announced the appointment of Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

Congress in Bruges, Belgium. The analysis will be presented at a Satellite Symposium organized by Abbott. The results support the robustness of the treatment effects and underscore the potential for ...

Good day and welcome to the Vertex Pharmaceuticals third-quarter 2024 earnings call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to ...

Since the law went into effect, the EEOC has reported that it has received more than 2,000 charges alleging violation of the ...